Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Number of employees : 71 000 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Pharmaceutical37,68988.8%41,75189.6% +10.78%
Animal Health4,2129.9%4,3939.4% +4.3%
Other143.000.3%521.001.1% +264.34%
Other Segment250.000.6%175.000.4% -30%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States18,21242.9%20,32543.6% +11.6%
Europe, Middle East and Africa12,21328.8%12,70727.3% +4.04%
Japan3,2127.6%3,5837.7% +11.55%
China2,1845.1%3,2076.9% +46.84%
Asia Pacific2,9096.9%2,9436.3% +1.17%
Latin America2,4155.7%2,4695.3% +2.24%
Other1,1492.7%1,6063.4% +39.77%
Managers and Directors
NameAgeSinceTitle
Kenneth Frazier652011Chairman, President & Chief Executive Officer
Robert M. Davis542016CFO & Executive Vice President-Global Services
Sandy Tremps-2016Vice President-R&D IT CIO
Thomas Henry Glocer602007Independent Director
Leslie Brun682014Lead Independent Director
Patricia Russo671995Independent Director
Peter C. Wendell692003Independent Director
Thomas Robert Cech, Dr.722009Independent Director
Pamela J. Craig632015Independent Director
Paul B. Rothman, Dr.622015Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,577,377,827 2,528,063,047 70.7% 1,047,343,390 29.3% 70.7%
Shareholders
NameEquities%
The Vanguard Group, Inc. 198,015,248 7.83%
Capital Research & Management Co. 138,704,087 5.48%
SSgA Funds Management, Inc. 117,030,114 4.63%
BlackRock Fund Advisors 63,007,524 2.49%
Wellington Management Co. LLP 44,729,366 1.77%
Geode Capital Management LLC 41,363,672 1.63%
Capital Research & Management Co. (International Investors) 38,213,851 1.51%
Northern Trust Investments, Inc.(Investment Management) 33,740,381 1.33%
Janus Capital Management LLC 27,740,360 1.10%
Norges Bank Investment Management 27,531,123 1.09%
Holdings
NameEquities%Valuation
NGM Biopharmaceuticals, Inc. (NGM) 12,955,01618.8%307,033,879 USD
Sutro Biopharma, Inc. (STRO) 2,723,5097.05%46,572,004 USD
KalVista Pharmaceuticals, Inc. (KALV) 1,070,5895.98%20,030,720 USD
Yumanity Therapeutics, Inc. (YMTX) 10,539,98020.2%11,172,379 USD
4D pharma plc (DDDD) 7,661,0005.83%9,777,811 USD
OpGen, Inc. (OPGN) 10,8270.054%21,546 USD
Company contact information
Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth, NJ 07033

Phone : +1.908.740.4000
Web : http://www.merck.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck & Co., Inc.
Sector Pharmaceuticals - NEC